HOOKIPA Pharma Inc. (HOOK)
OTCMKTS · Delayed Price · Currency is USD
1.060
+0.010 (0.95%)
Feb 5, 2026, 4:00 PM EST
HOOKIPA Pharma Market Cap
HOOKIPA Pharma has a market cap or net worth of $13.63 million as of February 6, 2026. Its market cap has decreased by -45.37% in one year.
Market Cap
13.63M
Enterprise Value
-26.05M
Revenue
9.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.06
Market Cap Chart
Since April 18, 2019, HOOKIPA Pharma's market cap has decreased from 355.72M to 13.63M, a decrease of -96.17%. That is a compound annual growth rate of -38.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 13.63M | 19.13% |
| Dec 31, 2025 | 11.44M | -54.60% |
| Dec 31, 2024 | 25.20M | -75.19% |
| Dec 29, 2023 | 101.56M | 73.63% |
| Dec 30, 2022 | 58.49M | -23.78% |
| Dec 31, 2021 | 76.74M | -76.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Finch Therapeutics Group | 22.06M |
| Provectus Biopharmaceuticals | 19.21M |
| Zeo ScientifiX | 17.21M |
| EOM Pharmaceuticals Holdings | 15.18M |
| GPL Holdings | 13.61M |
| TRON Group | 13.46M |
| Inhibitor Therapeutics | 9.49M |
| AccuStem Sciences | 9.35M |